Home > Insider Trading > Filing (0001628280-19-010823)

Filing Details

Accession Number:: 0001628280-19-010823
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-15 16:03:56
Reporting Period:: 2019-08-13

Accepted Time:: 2019-08-15 16:03:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1397702	Silk Road Medical Inc	SILK	Surgical & Medical Instruments & Apparatus (3841)	208777622

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1414561	Warburg Pincus X, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1414564	L.p. Gp X Pincus Warburg	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1414565	Warburg Pincus Private Equity X, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1451560	Warburg Pincus X Partners, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1621224	Warburg Pincus Partners Gp Llc	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1621242	Warburg Pincus Partners, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1621874	Wpp Gp Llc	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1770767	Wp X Finance, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No
1770772	Wpx Gp, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-08-13	630,000	$39.50	7,406,301	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), 610,470 shares were sold by WP X Finance, L.P. ("WP X Finance") and 19,530 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP") upon exercise of the underwriter's overallotment option.
Pursuant to the Offering, on August 8, 2019, the Issuer, WP X Finance, WPXP, other selling stockholders, and the underwriters of the Offering (the "Underwriters"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,793,328 shares of common stock of the Issuer to the Underwriters, including an aggregate of 630,000 shares upon exercise of the Underwriters' overallotment option. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
7,176,711 of these shares are held by WP X Finance and 229,590 of these shares are held by WPXP.
WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
(continuation from footnote 3) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Charles R. Kaye and Joseph P. Landy are each Managing General Partners of WP and may each be deemed to control the Warburg Pincus entities. Messrs. Kaye and Landy disclaim beneficial ownership of all shares held by the Warburg Pincus entities.